Rhus toxicodendron (Schwabe North America, Inc)
Welcome to the PulseAid listing for the Rhus toxicodendron drug offered from Schwabe North America, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Schwabe North America, Inc |
NON-PROPRIETARY NAME: | Rhus toxicodendron |
SUBSTANCE NAME: | TOXICODENDRON PUBESCENS LEAF |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | SUBLINGUAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2006-01-01 |
END MARKETING DATE: | 2018-09-30 |
Rhus toxicodendron HUMAN OTC DRUG Details:
Item Description | Rhus toxicodendron from Schwabe North America, Inc |
LABELER NAME: | Schwabe North America, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30([hp_C]/1) |
START MARKETING DATE: | 2006-01-01 |
END MARKETING DATE: | 2018-09-30 |
PRODUCT ID: | 53499-4671_fce51964-2419-4b92-9f33-d91df2d26dc1 |
PRODUCT NDC: | 53499-4671 |
APPLICATION NUMBER: | |
Other TOXICODENDRON PUBESCENS LEAF Pharmaceutical Manufacturers / Labelers: